Drugs & Targets FDA grants orphan drug designation to SELLAS’s WT1 cancer vaccine March 04, 2016Vol.42 No.09
Drugs & Targets Imbruvica Granted 5th Approval, For First-Line CLL Patients March 04, 2016Vol.42 No.09
Funding Opportunities FDA Providing $2 Million for Natural History Studies in Rare Diseases March 04, 2016Vol.42 No.09By Sarah Pavlovna Goldberg
In Brief IBM and New York Genome Center to collaborate using Watson technology March 04, 2016Vol.42 No.09
National Academy of Medicine Publishes Report on Categorizing Different Ovarian Cancers March 04, 2016Vol.42 No.09
In Brief Michael Bukosky appointed chief operating officer of USMD Holdings Inc. March 04, 2016Vol.42 No.09
